earnings
LY
NASDAQ · LYEL
Lyell Immunopharma, Inc.
Healthcare · Biotechnology
$11.01
Up+$0.21 (+1.94%)
Updated Sep 20, 2026, 10:28 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 708.04M
- P/E ratio
- -1.87
- Dividend yield
- 0.00%
- 52-week range
- $10.46 – $45.00
- Volume
- 401.13K
- Avg. volume
- 48.46K
Price performance
LYEL price history
1M range · 19 trading sessions · Daily adjusted prices
LYEL closed at $11.01 after 19 trading sessions, down 25.31% for the selected period.
- Last close
- $11.01
- Period change
- -25.31%
- Period low
- $10.78
- Period high
- $15.49
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $10.75 | $11.045 | $10.53 | $11.01 | 401.13K |
| Sep 17, 2026 | $11.01 | $11.06 | $10.60 | $10.80 | 133K |
| Sep 16, 2026 | $10.90 | $10.9799 | $10.46 | $10.775 | 154.7K |
| Sep 15, 2026 | $11.29 | $11.29 | $10.55 | $10.91 | 184.15K |
| Sep 14, 2026 | $11.97 | $12.385 | $11.24 | $11.33 | 104.41K |
| Sep 11, 2026 | $12.41 | $13.00 | $11.70 | $11.96 | 152.2K |
| Sep 10, 2026 | $12.70 | $12.71 | $12.04 | $12.20 | 111.12K |
| Sep 9, 2026 | $13.52 | $13.82 | $12.71 | $12.88 | 101.57K |
| Sep 8, 2026 | $14.12 | $14.13 | $13.37 | $13.53 | 83K |
| Sep 4, 2026 | $14.29 | $14.68 | $13.92 | $14.37 | 54.07K |
| Sep 3, 2026 | $15.11 | $15.14 | $14.19 | $14.32 | 79.05K |
| Sep 2, 2026 | $14.49 | $14.97 | $14.25 | $14.955 | 56.86K |
| Sep 1, 2026 | $14.14 | $14.835 | $14.00 | $14.525 | 67.01K |
| Aug 31, 2026 | $14.51 | $14.71 | $14.14 | $14.32 | 62.77K |
| Aug 28, 2026 | $14.56 | $14.78 | $14.06 | $14.53 | 78.12K |
| Aug 27, 2026 | $14.67 | $15.02 | $14.33 | $14.61 | 88.38K |
| Aug 26, 2026 | $15.34 | $15.4102 | $14.61 | $14.80 | 87.78K |
| Aug 25, 2026 | $15.02 | $15.68 | $14.92 | $15.49 | 103K |
| Aug 24, 2026 | $15.30 | $15.49 | $14.46 | $14.74 | 73.24K |
Latest LYEL news
The latest Smart Investors Daily articles mentioning LYEL.
Stock researchMarket Activity · Insider Trades
Loading stock research…

